Medicine, Inova Fairfax Hospital, Falls Church, Virginia, USA
Adult Cystic Fibrosis Program, Inova Fairfax Hospital, Falls Church, Virginia, USA.
BMJ Case Rep. 2021 Dec 31;14(12):e245441. doi: 10.1136/bcr-2021-245441.
We present the first reported case of pulmonary infection presenting as lung nodules. The patient is a 31-year-old man with cystic fibrosis (CF) colonised with multidrug-resistant and increased frequency of pulmonary exacerbations in the preceding months. While on intravenous antibiotics for a pulmonary exacerbation, he developed bilateral pulmonary nodules. Bronchoalveolar lavage cultures grew He was initially treated with dual antifungal therapy, voriconazole and micafungin. Discontinuation of voriconazole due to transaminitis resulted in the development of new nodules, and isavuconazonium was added. Repeat imaging revealed no progression of disease. Micafungin was eventually discontinued. Monotherapy with isavuconazonium is planned for 1 year post lung transplant. In the CF population, may be an opportunistic pathogen. The case highlights that frequent CF exacerbations and antibiotic exposure increase the risk for opportunistic infections including species and the implications for lung transplantation in this setting.
我们报告了首例以肺结节为表现的肺部感染病例。患者为 31 岁男性,患有囊性纤维化(CF),定植有多种耐药菌,且在前几个月中肺部恶化的频率增加。在因肺部恶化接受静脉内抗生素治疗期间,他出现双侧肺结节。支气管肺泡灌洗培养出 他最初接受了两性霉素 B 联合米卡芬净的抗真菌治疗。由于肝转氨酶升高而停用伏立康唑后,出现新的结节,并加用了伊曲康唑。重复影像学检查显示疾病无进展。最终停用了米卡芬净。计划在肺移植后 1 年进行伊曲康唑单药治疗。在 CF 人群中, 可能是一种机会性病原体。该病例强调了频繁的 CF 恶化和抗生素暴露会增加包括 种在内的机会性感染的风险,以及这对该人群进行肺移植的影响。